Keywords
Abstract
Semizlik homiladorlik davrida metabolik buzilishlar va surunkali past darajadagi yallig‘lanish jarayonlari bilan kechib, preeklampsiya rivojlanish xavfini oshiruvchi muhim omillardan biri hisoblanadi. Mazkur tadqiqotning maqsadi semizlik mavjud homilador ayollarda insulin rezistentligi hamda yallig‘lanish markerlarining preeklampsiyani erta bashorat qilishdagi ahamiyatini baholashdan iborat. Tadqiqot davomida homilador ayollarning antropometrik ko‘rsatkichlari, metabolik holati va laborator biomarkerlari tahlil qilinadi. Insulin rezistentligini baholashda och qoringa glyukoza va insulin miqdori hamda HOMA-IR ko‘rsatkichi, yallig‘lanish jarayonini aniqlashda esa C-reaktiv oqsil, interleykin-6 va boshqa tegishli markerlardan foydalanish mumkin.
References
1. Roberts J.M., Bodnar L.M., Patrick T.E., Powers R.W. The Role of Obesity in Preeclampsia. Pregnancy Hypertension. 2013.
2. Spradley F.T. Increased Risk for the Development of Preeclampsia in Obese Pregnancies: Weighing in on the Mechanisms. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2017.
3. Roberts J.M., Hubel C.A. The Two Stage Model of Preeclampsia: Variations on the Theme. Placenta. 2009.
4. Sibai B.M., Ewell M., Levine R.J. et al. Risk Factors Associated with Preeclampsia in Healthy Nulliparous Women. American Journal of Obstetrics and Gynecology. 1997.
5. Mol B.W.J., Roberts C.T., Thangaratinam S. et al. Pre-eclampsia. The Lancet. 2016;387:999–1011.
6. Phipps E., Prasanna D., Brima W., Jim B. Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clinical Journal of the American Society of Nephrology. 2016;11:1102–1113.
7. Fasshauer M., Blüher M., Stumvoll M. Adipokines in Gestational Diabetes. The Lancet Diabetes & Endocrinology. 2014.